Praxis Awarded Patient Recruitment Contract for HCV Research Program
Praxis, a company specializing in centralized patient recruitment for clinical research studies, is extending patient recruitment services to a top 20 pharmaceutical company for an international Hepatitis C Virus (HCV) study. The study explores an investigational drug’s effectiveness for this condition affecting almost 4 million Americans. This second protocol’s recruitment program will build on the success of the initial campaign.
This will be the second in a series of branded studies for this indication. Through Praxis’ analysis of results from the first study, a customized marketing strategy and extension of the brand campaign was developed to successfully motivate individuals with HCV to consider participation in the study. Praxis will continue to provide a variety of recruitment services for the study, including strategic planning, website development, public relations/community outreach, patient education materials, along with a mix of other appropriate direct-to-candidate communications.
“Social science has proven that individuals are more likely to respond to a known brand and that their recall of a familiar message is higher. This leads to increased response rates from all forms of outreach,” explains David Fox, president and CEO of Praxis. “Implementing branded continuum campaigns, such as this, brings about exponentially greater results. This approach, when executed effectively, provides new levels of success and efficiency. ”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
